Literature DB >> 12055677

Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.

Hiroaki Fujii1, Toshiharu Matsumoto, Manabu Yoshida, Yoshiaki Furugen, Tetsuya Takagaki, Keiichi Iwabuchi, Yasuo Nakata, Yoshitake Takagi, Takuya Moriya, Naomi Ohtsuji, Mareki Ohtsuji, Sachiko Hirose, Toshikazu Shirai.   

Abstract

Synchronous development of carcinomas in the endometrium and ovaries is a fairly common phenomenon, but distinction of a single clonal tumor with metastasis from 2 independent primary tumors may present diagnostic problems. To determine clonality and the occurrence of progression, we microdissected multiple foci from 17 cases of synchronous endometrioid carcinomas and studied loss of heterozygosity (LOH), microsatellite instability (MI), and PTEN mutations. In 14 of the 17 cases, genetic alterations were either homogeneous or found in only some of the foci. LOH was detected for 10q (4 cases), 17p (2 cases), and 2p, 5q, 6q, 9p, 11q, 13q, and 16q (1 case each). Four cases had the MI phenotype with discordant MI patterns between both tumor sites, thus indicating a biclonal or triple clonal process. In 3 of 6 cases with PTEN mutations, identical mutations in both tumor sites indicated a single clonal neoplasm. Altogether, 14 synchronous tumors were genetically diagnosed as follows: single clonal tumor, characterized by concordant genetic alterations in both tumor sites, including identical LOH, identical PTEN mutations, and/or identical sporadic allelic instability patterns (4 cases); single clonal tumor with genetic progression, homogeneous LOH or identical PTEN mutations in both tumor sites and progressive LOH in ovarian metastatic foci (2 cases); and double (7 cases) or triple clonal tumors (1 case), determined by discordant PTEN mutations, heterogeneous LOH, and/or discordant MI patterns. Thus, 35% of synchronous tumors were monoclonal, 47% were polyclonal, and 18% were undetermined. The favorable prognosis of synchronous endometrioid carcinomas may be due to the occurrence of PTEN mutations in both independent and metastatic tumors, the MI-positive independent primary tumors, and the low frequency of LOH. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12055677     DOI: 10.1053/hupa.2002.124118

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

1.  Differential vimentin expression in ovarian and uterine corpus endometrioid adenocarcinomas: diagnostic utility in distinguishing double primaries from metastatic tumors.

Authors:  Mohamed M Desouki; Sarah J Kallas; Dineo Khabele; Marta A Crispens; Omar Hameed; Oluwole Fadare
Journal:  Int J Gynecol Pathol       Date:  2014-05       Impact factor: 2.762

Review 2.  The search for genes contributing to endometriosis risk.

Authors:  Grant W Montgomery; Dale R Nyholt; Zhen Zhen Zhao; Susan A Treloar; Jodie N Painter; Stacey A Missmer; Stephen H Kennedy; Krina T Zondervan
Journal:  Hum Reprod Update       Date:  2008-06-05       Impact factor: 15.610

3.  [Differential diagnosis of ovarian metastases].

Authors:  S Hauptmann
Journal:  Pathologe       Date:  2007-05       Impact factor: 1.011

4.  Expression of Somatostatin Receptor Type 2A and PTEN in Neuroendocrine Neoplasms Is Associated with Tumor Grade but Not with Site of Origin.

Authors:  Hideo Wada; Katsuya Matsuda; Yuko Akazawa; Yuka Yamaguchi; Shiro Miura; Nozomi Ueki; Akira Kinoshita; Koh-Ichiro Yoshiura; Hisayoshi Kondo; Masahiro Ito; Takeshi Nagayasu; Masahiro Nakashima
Journal:  Endocr Pathol       Date:  2016-09       Impact factor: 3.943

5.  Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas.

Authors:  Wilko Weichert; Carsten Denkert; Aurelia Noske; Silvia Darb-Esfahani; Manfred Dietel; Steve E Kalloger; David G Huntsman; Martin Köbel
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

6.  Genomic variability within an organism exposes its cell lineage tree.

Authors:  Dan Frumkin; Adam Wasserstrom; Shai Kaplan; Uriel Feige; Ehud Shapiro
Journal:  PLoS Comput Biol       Date:  2005-10-28       Impact factor: 4.475

7.  Triple malignancy in a single patient including a squamous cell carcinoma of the cervix, a colloid adenocarcinoma of the colon and a lung adenocarcinoma: A case report and literature review.

Authors:  Tarik Mahfoud; Rachid Tanz; Réda M Khmamouche; Massine M El Hammoumi; Mohamed Allaoui; Rhizlane Belbaraka; Mohamed Ichou
Journal:  Int J Surg Case Rep       Date:  2017-11-15

Review 8.  Potential for Mitochondrial DNA Sequencing in the Differential Diagnosis of Gynaecological Malignancies.

Authors:  Anna Myriam Perrone; Giulia Girolimetti; Martina Procaccini; Lorena Marchio; Alessandra Livi; Giulia Borghese; Anna Maria Porcelli; Pierandrea De Iaco; Giuseppe Gasparre
Journal:  Int J Mol Sci       Date:  2018-07-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.